PI
-
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Dimopoulos, M. A., Terpos, E., Boccadoro, M., Moreau, P., Mateos, M.-V., Zweegman, S., Cook, G., Engelhardt, M., Delforge, M., Hajek, R., Schjesvold, F., Gay, F., Manier, S., Weisel, K. C., Kaiser, M., van de Donk, N. W. C. J., Zamagni, E., Rodriguez-Otero, P., Perrot, A. & Driessen, C. & 13 others, , Sept 2025, In: Nature reviews. Clinical oncology. 22, 9, p. 680-700 21 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results
Corre, J., Vincent, L., Moreau, P., Hebraud, B., Hulin, C., Béné, M.-C., Broijl, A., Caillot, D., Delforge, M., Dejoie, T., Facon, T., Lambert, J. R., Leleu, X., Macro, M., Perrot, A., Zweegman, S., Filleron, T., Cabarrou, B., van de Donk, N. W. C. J. & Mahéo, S. & 11 others, , 7 Aug 2025, In: Blood. 146, 6, p. 679-692 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
van de Donk, N. W. C. J., Moreau, P., San-Miguel, J. F., Mateos, M.-V., Dimopoulos, M. A., Zweegman, S., Gay, F., Engelhardt, M., Mina, R., Zamagni, E., Delforge, M., Beksac, M., Spencer, A., Schjesvold, F., Driessen, C., Kaiser, M., Perrot, A., Wäsch, R., Korst, C. L. B. & Broijl, A. & 12 others, , Aug 2025, In: The Lancet Haematology. 12, 8, p. e635-e649Research output: Contribution to journal › Review article › Academic › peer-review
- All publications